ArtiVisc OVD from Ophtec
1% NaHA with >5 million Daltons Molecular Weight and high Viscosity: 1 million cPs Zero shear rate, in 0,55ml and 0,85ml syringe. 27G cannula.
Showing all 17 results
1% NaHA with >5 million Daltons Molecular Weight and high Viscosity: 1 million cPs Zero shear rate, in 0,55ml and 0,85ml syringe. 27G cannula.
1,4% NaHA with >5 million Daltons Molecular Weight and high Viscosity: 3.3 million cPs Zero shear rate, in 0,55ml and 0,85ml syringe. 25G cannula.
2% Sodium Hyaluronate with high molecular weight (3.o mill Dalton) and high Zero shear Viscosity of 900.000 mPas.
1ml Syringe on a 27G Cannula, NaHa 1,55%, MW at 2.2 Million Dalton and 170.000 mPascalsecond zero shear viscosity (COHESIVE)
Viscoat: Medium Viscosity Dispersive (Viscosity Zero Shear stress 40.000cps), 3% NaHA-4% Chondroitin Sulfate
ProVisc: Viscous Cohesive, 1% NaHA, 2.4million Dalton and Dynamic Viscosity 39.000 cps. Use during Capsulorhexis and IOL placement,
Each Container has two OVDS
a/ Healon Endocoat : 800.000mil Dalton MW, 3 % concentration with zero shear Viscosity of 50.000 mPas. 0,85 ml Volume. Dispersive
b/ Healon Pro : 3,2 mill Dalton, 1% concentration, prototype of Viscoelastics with zero shear viscosity of 150.000mPas Cohesive 0,55ml
5.000.000 mil Dalton MW, 1.4% concentration, prototype of supercohesive with zero shear Viscosity of 2.500.000 mPas. 0.55 and 0.85ml Volumes
1,8% NaHA with high Molecular Weight (3 mill Daltons) and quite high Viscosity: 210.000mPs, Zero shear rate, in 1,2 ml syringe. 25G cannula.
1% NaHA with 1.0Million Daltons Molecular Weight and high Viscosity: 1 million cPs Zero shear rate, in 0,55ml and 0,85ml syringe. 27G cannula.
Animal Origin, 1% NaHA, High molecular Weight (5mill) resulting in high Viscosity and Pseudoplasticity resulting in good space creation and controlled IOL injection and facilitating easy removal at the end of Surgery
Animal Origin, 1,4% NaHA, High molecular Weight (5mill) resulting in high Viscosity and Pseudoplasticity resulting in good space creation and controlled IOL injection and facilitating easy removal at the end of Surgery
Obtained by Biofermentation NOT Anmal Origin, 1,6% NaHA, High molecular Weight -Dalton (3mill) resulting in quite high Viscosity and Pseudoplasticity resulting in good space creation and controlled IOL injection and facilitating easy removal at the end of Surgery. 1,1 ml Syringe Volume , 27 G Cannula!
Classified by Company as Cohesive
Obtained by Biofermentation NOT Anmal Origin, 1,8% NaHA, High molecular Weight -Dalton (3mill) resulting in good cohesivity at low shear-rates (Zero Shear Viscosity ~600.000 mPas- but also strong coating ability (improved dispersive Properties) Easy removal at the end of Surgery. 1,1 ml Syringe Volume , 27 G Cannula!
Classified by Company as Cohesive
Animal Origin, 2,5% NaHA, High molecular Weight -Dalton (4mill) resulting in high Viscosity and Pseudoplasticity resulting in good space creation and controlled IOL injection and facilitating easy removal at the end of Surgery. 0,85ml Syringe Volume , 25 G Cannula!
Classified by Company as Visco-Adaptive (under Stress it behaves like dispersive)
ALBOMED specializes in Viscoelastic Product from Rooster Comb extract and Biofermentation as well as HPMC. Trypan Blue addition was patented and introduced in 2015. (NaHA 1.7%, MW between 1-2 mill Dalton) Zero Shear Viscosity unknown.
ALBOMED specializes in Viscoelastic Product from Rooster Comb extract and Biofermentation as well as HPMC. This 2% HPMC formulation in monodose formulation is specialized in loading IOLs into injectors and protection of the ocular surface during surgery
Topical Monodose 0,3% NaHA and 2% Lidocaine
Intracameral 1% NaHA or 1,5% both of MW 2.5 mill Dalton and Zero Shear Viscosity of 100.000 and 220.000 mPas respectively. Both formulations iclude 1% Lidocaine.
Syringe volume 0,8ml